Lynch syndrome screening implementation: Business analysis by a healthcare system

American Journal of Managed Care

Volumn 17, Issue 8, 2011, Pages

  Gudgeon, James M ^a   Williams, Janet L ^a   Burt, Randall W ^a   Samowitz, Wade S ^a   Snow, Gregory L ^a   Williams, Marc S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ARTICLE; CANCER PATIENT; CANCER SCREENING; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COLORECTAL CANCER; COST EFFECTIVENESS ANALYSIS; ELECTRONIC DATA INTERCHANGE; HEALTH PROGRAM; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; IMMUNOHISTOCHEMISTRY; INTEGRATED HEALTH CARE SYSTEM; MEDICAL DECISION MAKING; MEDLINE; MICROSATELLITE INSTABILITY; MORTALITY; MUTATIONAL ANALYSIS; NARRATIVE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SENSITIVITY AND SPECIFICITY; SIMULATION; SYSTEMATIC REVIEW;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; MODELS, ECONOMIC;

EID: 80052093745     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hampel H, Frankel WL, Martin E, et al. Feasibility of screening for Lynch syndrome among patients with colorectal cancer. J Clin Oncol. 2008;26(35):5783-5788.
2. Hampel H, Frankel WL, Martin E, et al. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med. 2005;352(18):1851- 1860.
3. Palomaki GE, McClain MR, Melillo S, Hampel HL, Thibodeau SN. EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med. 2009;11(1):42-65.
4. Bouzourene H, Hutter P, Losi L, Martin P, Benhattar J. Selection of patients with germline MLH1 mutated Lynch syndrome by determination of MLH1 methylation and BRAF mutation. Fam Cancer. 2010;9(2):167-172.
5. Chang SC, Lin PC, Yang SH, Wang HS, Liang WY, Lin JK Taiwan hospital-based detection of Lynch syndrome distinguishes 2 types of microsatellite instabilities in colorectal cancers. Surgery. 2010;147(5):720-728.
6. Gardner IA, Stryhn H, Lind P, Collins MT. Conditional dependence between tests affects the diagnosis and surveillance of animal diseases. Prev Vet Med. 2000;45(1-2):107-122. (Pubitemid 30308342)
7. Smith RD, Slenning BD. Decision analysis: dealing with uncertainty in diagnostic testing. Prev Vet Med. 2000;45(1-2):139-162. (Pubitemid 30308344)
8. Environmental Protection Agency. Risk Assessment Guidance for Superfund (RAGS) Volume III - Part A: Process for Conducting Probabilistic Risk Assessment (2001). http://www.epa.gov/oswer/riskassessment/rags3adt/.
9. Sleeper A. Six Sigma Distribution Modeling. San Francisco, CA: McGraw-Hill; 2006.
10. Mvundura M, Grosse SD, Hampel H, Palomaki GE. The cost-effectiveness of genetic testing strategies for Lynch syndrome among newly diagnosed patients with colorectal cancer. Genet Med. 2010;12(2):93-104.